S&Co Inc Organon & Co. Transaction History

S&Co Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$23.31 - $28.61 $209,160 - $256,717	-8,973 Reduced 46.78%	10,207 $285,000
Q3 2022 Nov 09, 2022	SELL	$23.4 - $34.25 $226,371 - $331,334	-9,674 Reduced 33.53%	19,180 $448,000
Q2 2022 Aug 09, 2022	SELL	$31.66 - $38.9 $156,495 - $192,282	-4,943 Reduced 14.63%	28,854 $973,000
Q1 2022 May 05, 2022	SELL	$30.45 - $39.36 $5,694 - $7,360	-187 Reduced 0.55%	33,797 $1.18 Million
Q4 2021 Feb 08, 2022	SELL	$28.67 - $37.13 $65,625 - $84,990	-2,289 Reduced 6.31%	33,984 $1.03 Million
Q3 2021 Nov 09, 2021	SELL	$28.63 - $35.64 $88,838 - $110,590	-3,103 Reduced 7.88%	36,273 $1.19 Million
Q2 2021 Jul 14, 2021	BUY	$28.45 - $38.0 $1.12 Million - $1.5 Million	39,376 New	39,376 $1.19 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of S&Co Inc, based on Form 13F filings with the SEC.

Stay updated on S&Co Inc with notifications on news.